HomeCompareDASTY vs JNJ

DASTY vs JNJ: Dividend Comparison 2026

DASTY yields 1.51% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DASTY wins by $2.53M in total portfolio value
10 years
DASTY
DASTY
● Live price
1.51%
Share price
$19.26
Annual div
$0.29
5Y div CAGR
85.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.55M
Annual income
$2,009,721.75
Full DASTY calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — DASTY vs JNJ

📍 DASTY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDASTYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DASTY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DASTY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DASTY
Annual income on $10K today (after 15% tax)
$127.99/yr
After 10yr DRIP, annual income (after tax)
$1,708,263.49/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, DASTY beats the other by $1,707,559.87/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DASTY + JNJ for your $10,000?

DASTY: 50%JNJ: 50%
100% JNJ50/50100% DASTY
Portfolio after 10yr
$1.29M
Annual income
$1,005,274.77/yr
Blended yield
78.20%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DASTY
Analyst Ratings
2
Hold
Consensus: Hold
Altman Z
3.0
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DASTY buys
0
JNJ buys
0
No recent congressional trades found for DASTY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDASTYJNJ
Forward yield1.51%3.36%
Annual dividend / share$0.29$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR85.6%5.8%
Portfolio after 10y$2.55M$20.0K
Annual income after 10y$2,009,721.75$827.78
Total dividends collected$2.48M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: DASTY vs JNJ ($10,000, DRIP)

YearDASTY PortfolioDASTY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,979$279.46$10,676$355.77+$303.00DASTY
2$12,280$532.22$11,407$389.39+$873.00DASTY
3$14,172$1,032.56$12,198$426.53+$2.0KDASTY
4$17,232$2,067.03$13,056$467.62+$4.2KDASTY
5$22,797$4,359.33$13,987$513.12+$8.8KDASTY
6$34,397$10,003.90$14,998$563.56+$19.4KDASTY
7$62,987$26,181.97$16,098$619.52+$46.9KDASTY
8$150,558$83,162.32$17,295$681.69+$133.3KDASTY
9$505,904$344,807.52$18,599$750.82+$487.3KDASTY
10$2,551,040$2,009,721.75$20,022$827.78+$2.53MDASTY

DASTY vs JNJ: Complete Analysis 2026

DASTYStock

Dassault Systèmes SE provides software solutions and services worldwide. It offers SOLIDWORKS design software for 3D design, electrical and printed circuit board design, product data management, simulation, manufacturing, and technical communication; CATIA, an engineering and design software for product 3D computer-aided design; GEOVIA for modeling and simulating the earth; and BIOVIA that provides the scientific community with advanced biological, chemical, and materials experiences. The company also provides SIMULIA that delivers realistic simulation applications; DELMIA, which enables global industrial operations; 3DVIA that provides 3D space planning solutions; and ENOVIA that enables to plan and track the definition of success for customer. In addition, it offers Centric PLM, a product lifecycle management software solution; 3DEXCITE, a real-time 3D visualization software; NETVIBES, which enables organizations to gather, align, and enrich big data; 3DEXPERIENCE platform that provides organizations a holistic and real-time view of their business activities and ecosystem, as well as connecting people, ideas, data, and solutions together in a single environment; and MEDIDATA, a clinical research study software that provides evidences and insights to pharmaceutical, biotech, medical device, and diagnostic companies, as well as academic researchers. Further, the company provides consulting, deployment, outcome based, and training services. It primarily serves companies in the transportation and mobility; industrial equipment; aerospace and defense; high-tech; life sciences and healthcare; energy and materials; home and lifestyle; construction, cities, and territories; consumer packaged goods and retail; marine and offshore; and business services sectors through distributors and resellers. Dassault Systèmes SE was incorporated in 1981 and is headquartered in Vélizy-Villacoublay, France.

Full DASTY Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this DASTY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DASTY vs SCHDDASTY vs JEPIDASTY vs ODASTY vs KODASTY vs MAINDASTY vs ABBVDASTY vs MRKDASTY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.